AS1810722, a fused bicyclic pyrimidine derivative, is an orally active and potent inhibitor of STAT6, demonstrating an IC50 of 1.9 nM. It exhibits effective inhibition of CYP3A4, positioning it as a promising candidate for research into allergic diseases, including asthma and atopic conditions.
Molecular Weight:
477.51
Purity:
99.13%
CAS Number:
[909561-15-5]
Formula:
C25H25F2N7O
Target:
Cytochromes P450|||STAT
T9043
* VAT and and shipping costs not included. Errors and price changes excepted
